GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM

大菲尼克斯社区临床肿瘤学计划

• 批准号: 2653984
• 负责人: DAVID K KING
• 金额: $ 26.08万
• 依托单位: BANNER GOOD SAMARITAN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 2003-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2653984
• 关键词: antidepressants; antineoplastic antibiotics; antineoplastics; aspirin; bone marrow transplantation; brain neoplasms; breast neoplasms; cancer information system; cancer prevention; cancer registry /resource; cancer rehabilitation /care; carmustine; chemoprevention; cis platinum compound; clinical research; clinical trials; colony stimulating factor; combination cancer therapy; cooperative study; cyclophosphamide; data management; doxorubicin; estrogens; fatigue; female reproductive system neoplasm; finasteride; fluorouracil; gastrointestinal neoplasms; hormone therapy; human subject; human therapy evaluation; leucovorin; leukemia; lung neoplasms; lymphoma; methotrexate; mifepristone; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer education; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; oncology nursing; paclitaxel; primary care physician; prostate neoplasms; suramin; tamoxifen; tumor necrosis factor alpha; urinary tract neoplasms

The Greater Phoenix Community Clinical Oncology Program (GPCCOP)is a consortium of five hospitals with 67 investigations led by principal investigator David K. King, M.D. Dr. King and many of the investigators have been associated with the CCOP since its initial planning stage in 1982. The continuing long-term goals and specific aims of the GPCCOP include: 1) increased clinical research activities; 2) access to additional clinical trials; 3) further development of cancer control research initiatives and patient accrual; 4) maintenance of quality data management; 5) pharmacy resources to coordinate and manage drug distribution; 6) involvement of primary care physicians in state-of-the- art cancer management and education; and 7) continued development of data management systems to support NCI evaluations. GPCCOP's organizational structure requires the involvement of the Co- Principal Investigators and hospital administrators from each of the participating institutions in the planning and policy-making decisions of the CCOP. The physicians, nurses and administrative staff have active roles in guiding the GPCCOP toward attainment of its goals. This experienced team has demonstrated their commitment and ability to accrue patients to both therapeutic and cancer control protocols while maintaining high levels of quality control and timely submissions. GPCCOP's data management systems were recognized by SWOG in 1991 with the Outstanding Achievement Award. Additional investigators, specializing in medical and radiation oncology, have been recruited to the GPCCOP to ensure the availability of total patient care for the 3000 average new patients seen each year. By adding investigators from the Tucson area and adding the GOG as a research base, a higher level of participation is expected. The above resources, the placement of 347 patients on treatment protocols and 1097 patients on cancer control trials during the period 1989 to present demonstrate GPCCOP's preparedness to continue its active participation in NCI's Community Oncology Program.

大凤凰城社区临床肿瘤学计划（GPCCOP）是一个 由五家医院组成的联盟，由主要负责人领导进行了67项调查 调查员大卫K. King，医学博士金博士和许多研究人员 自2001年开始规划以来， 1982. GPCCOP的长期目标和具体目标包括： 1)增加临床研究活动; 2）获得额外的 临床试验; 3）进一步开展癌症控制研究 主动性和患者增加; 4）质量数据的维护 管理; 5）协调和管理药物的药房资源 分布; 6）初级保健医生参与国家的- 艺术癌症管理和教育;以及7）继续发展 支持NCI评估的数据管理系统。 GPCCOP的组织结构需要联合国的参与， 来自各研究中心的主要研究者和医院管理人员 参与规划和决策的机构 的CCOP。 医生、护士和行政人员 在指导GPCCOP实现其目标方面发挥积极作用。 这 经验丰富的团队已经证明了他们的承诺和能力， 患者的治疗和癌症控制协议， 保持高水平的质量控制和及时提交。 GPCCOP的数据管理系统于1991年获得SWOG的认可， 杰出成就奖 其他调查员，专门从事医疗和放射 已被招募到GPCCOP，以确保可用性 每年平均有3000名新病人接受治疗。 通过增加图森地区的调查人员，并将GOG作为一个 研究基地，预计将有更高水平的参与。 利用上述资源，安排了347名病人接受治疗 在此期间，1097名患者接受了癌症控制试验 1989年至今表明GPCCOP准备继续其积极的 参与NCI的社区肿瘤学项目。